Spyker D A, Thomas B L, Sande M A, Bolton W K
Antimicrob Agents Chemother. 1978 Aug;14(2):172-7. doi: 10.1128/AAC.14.2.172.
The pharmacokinetics of cefaclor and cephalexin were characterized in patients with creatinine clearances ranging from 0 to 147 ml/min. Each of 24 fasted subjects received a single 500-mg oral dose of cefaclor, and 13 of these subjects later received 500 mg of cephalexin. Serum and urine levels of the antibiotics were measured by bioassay. The serum half-lives were highly correlated with corrected creatinine clearance (cefaclor r = 0.92, cephalexin r = 0.94). Linear regression estimates of the half-life of cefaclor were 2.3 h in the anephric patient and 40 min in the patient with a corrected creatinine clearance of 100 ml/min. For cephalexin, corresponding half-lives were 15.4 h and 58 min. We present a dosage nomogram for calculating the appropriate adjustments to the loading dose based on patient weight and maintenence dose based on corrected creatinine clearance.
对肌酐清除率在0至147毫升/分钟范围内的患者进行了头孢克洛和头孢氨苄的药代动力学研究。24名空腹受试者每人单次口服500毫克头孢克洛,其中13名受试者随后又服用了500毫克头孢氨苄。通过生物测定法测量抗生素的血清和尿液水平。血清半衰期与校正后的肌酐清除率高度相关(头孢克洛r = 0.92,头孢氨苄r = 0.94)。无肾患者头孢克洛半衰期的线性回归估计值为2.3小时,校正后肌酐清除率为100毫升/分钟的患者为40分钟。对于头孢氨苄,相应的半衰期分别为15.4小时和58分钟。我们提供了一个剂量列线图,用于根据患者体重计算负荷剂量的适当调整,并根据校正后的肌酐清除率计算维持剂量。